Insmed (INSM) Gross Profit (2018 - 2026)

Insmed's Gross Profit history runs 9 years deep, the most recent figure standing at $258.5 million for Q1 2026.

• On a quarterly basis, Gross Profit rose 261.37% year-over-year to $258.5 million in Q1 2026; TTM through Mar 2026 was $670.5 million, a 130.04% increase from a year earlier, with the FY2025 full-year figure at $483.5 million, up 73.94% from the prior year.
• Gross Profit improved to $258.5 million in Q1 2026 per INSM's latest filing, from $219.6 million in the prior quarter.
• Across five years, Gross Profit topped out at $258.5 million in Q1 2026 and bottomed at $40.9 million in Q1 2022.
• The 5-year median for Gross Profit is $65.2 million (2023), against an average of $85.3 million.
• Across the five-year window, Gross Profit rose 7.93% in 2022 and jumped 261.37% in 2026, its largest moves.
• Year by year, Gross Profit stood at $46.2 million in 2022, then surged by 41.14% to $65.2 million in 2023, then rose by 19.99% to $78.3 million in 2024, then soared by 180.52% to $219.6 million in 2025, then rose by 17.72% to $258.5 million in 2026.
• Per Business Quant, the three latest INSM Gross Profit figures stand at $258.5 million (Q1 2026), $219.6 million (Q4 2025), and $113.0 million (Q3 2025).